Skip to content

DM BIOMED DEVELOPMENT

Active Private limited companyfounded 2012active for 14 yearsRue des Montys 53, 4141 SprimontKBO/BCE: BE 0842.657.707
DM BIOMED DEVELOPMENT
Financial year 2025
Follow ReportCompare

Annual accounts 2025

micro format, filed on 24-02-2026, 65 days before the deadline
€45,196
▲ 59.7%
€44,039
▲ 64.9%
€44,487
▲ 61.2%
€30,980
▲ 42.3%
86.5%
▼ 8.7 percentage points
7.21
▼ 13.50

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €130,000. Estimated: probably between €79,000 and €180,000.

Money flows

no detail for 2025

Balance sheet

balance sheet total €124,632 on 30-09-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

86.5%

Higher than 85% of 39,364 companies in 2025.

7.21

Higher than 85% of 38,048 companies in 2025.

24.5%

Higher than 64% of 38,520 companies in 2025.

DM BIOMED DEVELOPMENT Middle half of the sector 80% of the sector Micro accounts in head offices and management consultancy (NACE 70)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202320222021202020192018201720162015201420132012
Balance sheet: assets
20/58 124,63281,14460,665131,528140,496109,33390,508209,815211,953178,684164,410135,219112,24695,242
21/28 3,5464061,2942,9793,1263,7696,8377,1336,1367,3964,3617,17710,044261
22/27 3,5464061,2942,9793,1263,7696,8377,1336,1367,3964,3617,17710,044261
24 963536711,289---1,219---6351,322261
26 2,5833546231,6913,1263,7696,8375,9146,1367,3964,3616,5428,722-
29/58 121,08680,73859,372128,549137,370105,56483,671202,682205,817171,288160,049128,042102,20194,981
3 11,4697,92413,17212,54010,97210,41210,0769,8469,910-----
30/36 11,4697,92413,17212,54010,97210,41210,0769,8469,910-----
40/41 22,87616,47817,12511,11720,94632,14316,73217,54711,61723,39817,78220,12419,45716,453
40 16,02712,1589,4716,21215,59331,20216,73112,89511,61714,33016,82520,12412,61913,004
41 6,8504,3217,6544,9055,35394114,652-9,068957-6,8373,450
50/53 -------140,68290,68290,68290,682---
54/58 83,99451,44721,50894,28692,01348,54056,15432,85092,36555,59849,170106,80780,65978,201
490/1 2,7474,8887,56710,60513,44014,4697091,7561,2421,6092,4141,1112,086327
Balance sheet: equity and liabilities
10/49 124,63281,14460,665131,528140,496109,33390,508209,815211,953178,684164,410135,219112,24695,242
10/15 107,77877,24656,36768,348106,699101,09168,811197,070185,061160,057144,05397,83518,45317,458
10/11 62,12462,12462,12462,12462,12462,12462,12462,12462,12462,12462,12462,12415,00015,000
100 ------62,12462,12462,12462,12462,12462,12418,60018,600
101 ------------3,6003,600
13 45,65415,1226,2126,2126,2126,2126,2126,2126,2126,2126,2123,4731,8601,500
130/1 ---6,2126,2126,212--------
130 ------6,2126,2126,2126,2126,2123,4731,8601,500
1311 ---6,2126,2126,212--------
133 45,65415,1226,212-----------
14 ---11,9701138,36332,754475128,734116,72591,72075,71632,2381,593958
17/49 16,8553,8994,29963,18033,7978,24221,69712,74526,89218,62820,35737,38493,79377,784
42/48 16,8053,8994,11463,18033,7978,14321,69712,74526,89218,62820,35737,38493,77177,681
44 4,7141,3331,7401,4831,0684979173,46091453375314,053116188
440/4 4,7141,3331,7401,4831,0684979173,46091453375314,053116188
45 12,0902,3622,3743,6972,7297,6462,5665,34015,4162,95012,16720,85251,65538,493
450/3 12,0902,3622,3743,6972,7297,6462,5665,34015,4162,95012,16720,85251,65535,268
454/9 -------------3,225
47/48 -204-58,00030,000-18,2143,94510,56115,1457,4372,47842,00039,000
492/3 50-185--100------22103
Income statement
70 ------------152,724-
9900 45,19628,293-7,53332,06049,75347,14542,67421,46741,07626,19370,94353,85473,21367,517
60/61 ------------88,204-
630 4478871,6862,0001,9913,0684,2873,4894,0413,4852,8162,8683,024157
640/8 7106961,1523219027916336046496241,3895541,1831,751
9901 44,03926,709-10,37029,73946,86043,28637,75517,37536,38722,08466,73950,43269,00665,610
75/76B 3351301573193014221,5301,4011,2802,437204766517
75 3351301573193014221,5301,4011,2802,437204766517
65/66B 1,2771,5181,5201,6231,9171,19911,6371,2221,3442,1472,9722,7852,3811,455
65 1,2771,5181,5201,6231,9171,19911,6371,2221,3442,1472,9722,7852,3811,455
9903 43,09825,321-11,73328,43545,24342,12926,12117,68236,44421,21766,20347,85167,39164,671
67/77 12,5664,4432488,7879,6359,8508,6465,67311,4395,21319,98515,59324,39623,214
9904 30,53220,879-11,98119,64935,60832,28017,47512,00925,00516,00446,21832,25842,99541,458
9905 30,53220,879-11,98119,64935,60832,28017,47512,00925,00516,00446,21832,25842,99541,458
Appropriation of the result
9906 30,5328,909-11,97058,01168,36332,754146,209128,734116,72591,72078,45633,85143,95341,458
14P --11,9701138,363----------
691/2 30,5328,909--------2,7391,6133601,500
6920 ----------2,7391,6133601,500
6921 30,5328,909------------
694/7 ---58,00030,000-145,734-----42,00039,000
694 ---58,00030,000-145,734-----42,00039,000
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 24-02-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
30-09-2025 micro format 24-02-2026 2026-00044607 PDF
30-09-2024 micro format 25-04-2025 2025-00082977 PDF
30-09-2023 micro format 19-02-2024 2024-00032288 PDF
30-09-2022 micro format 05-04-2023 2023-00057115 PDF
30-09-2021 micro format 10-03-2022 2022-07500157 PDF
30-09-2020 micro format 08-02-2021 2021-05000336 PDF
30-09-2019 micro format 13-02-2020 2020-05100106 PDF
30-09-2018 full format 21-02-2019 2019-05600307 PDF
30-09-2017 full format 09-02-2018 2018-04800041 PDF
30-09-2016 full format 02-03-2017 2017-05700532 PDF
30-09-2015 full format 04-02-2016 2016-03900090 PDF
30-09-2014 full format 11-02-2015 2015-04000346 PDF
30-09-2013 full format 19-02-2014 2014-04200330 PDF
30-09-2012 full format 08-04-2013 2013-08600594 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202320222021202020192018201720162015201420132012
44,48727,597-8,68531,74048,85146,35342,04220,86440,42725,56869,55453,29972,03065,766
30,98021,766-10,29521,64937,59935,34721,76215,49829,04519,48849,03335,12646,01941,614
3,587001,8541,34703,9914,4862,7806,520012,29012,807418
32,54629,940-72,7782,27443,473-7,61423,304-59,51536,7676,427-57,63626,1482,458-
104,28276,83955,25765,368103,57397,42161,974189,937178,925152,660139,69290,6588,43117,300
------------45.2%-
86.5%95.2%92.9%52.0%75.9%92.5%76.0%93.9%87.3%89.6%87.6%72.4%16.4%18.3%
7.2120.7114.432.034.0612.963.8615.907.659.207.863.431.091.22
6.5218.6811.231.843.7411.693.3915.137.299.207.863.431.091.22
0.160.050.080.920.320.080.320.060.150.120.140.385.084.46
28.3%27.0%-21.3%28.7%33.4%31.9%25.4%6.1%13.5%10.0%32.1%33.0%233.0%237.5%
24.5%25.7%-19.7%14.9%25.3%29.5%19.3%5.7%11.8%9.0%28.1%23.9%38.3%43.5%
34.8418.18-5.7119.56----------
------------30 days-
------------0 days-

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item30-09-202530-09-202430-09-202330-09-2022
Tangible fixed assets€3,587--€1,854
€447€887€1,686€2,000

Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)

Insights on DM BIOMED DEVELOPMENT

The operating result for 2025 is 65% higher than in 2024 and the highest since 2021. It is the second rise in a row, after the fall in 2023.

Debt's share of the balance-sheet total rises from 4.8% to 13.5%. Equity and debt are higher.

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

We would like to set cookies. That happens only with your consent. What we measure